罗 雷 博士 教授 博士生导师

西南大学药学院 院长

国家万人计划领军人才，国家重点研发计划青年首席，农业农村部新兽药咨询评审专家，重庆市学术技术带头人，西南大学“含弘英才岗”教授

学士、硕士、博士，分别毕业于中国药科大学、英国Loughborough University和University of Sheffield。

主持“十四五”国家重点研发计划青年科学家项目、重庆市杰出青年科学基金项目、国家自然科学基金和重庆市科技项目等科技开发项目30余项。研发的国内首个动物专用利胆药孟布酮（化药类），获国家二类新兽药证书3项，制定新兽药国家标准和残留检测标准4项；获人用药新药临床批件1项；获美国发明专利授权1项、中国发明专利授权5项；在药学期刊Adv. Sci., J. Control Release, Acta Pharm. Sin. B等发表论文20余篇；获 “2021十大重庆科技创新年度人物”称号，2022“强国青年科学家”提名人选。任Asian J. Pharm.编委、中国畜牧兽医学会兽医药理毒理学分会常务理事、中国药品监督管理研究会理事、重庆市药品监督管理局药械妆专家委员会委员、重庆市药学会药理专委会副主任委员、重庆市药学会药剂专委会副主任委员、重庆市兽药工程技术中心主任、国家生猪技术创新中心特聘研究员、国家奶牛疾病防治科技创新联盟常务理事。

主讲《药剂学》、《工业药剂学》、《生物药剂学与药物动力学》等课程，全英文《药剂学》被重庆市教委评为重庆市来华留学英语授课品牌课程。指导学生获中国国际“联网+”大学生创新创业大赛重庆赛区选拔赛金奖。

研究方向为药物制剂、新药/新兽药和药用辅料的创制及产业化。

PUBLICATIONS （代表作）

1. Q. Wu, Y. Chen, Q. Li, J. Chen, J. Mo, M. Jin, Q. Yang, L. Rizzello, X. Tian, and L. Luo*. Time Rules the Efficacy of Immune Checkpoint Inhibitors in Photodynamic Therapy [J]. Advanced Science, 2022, 2200999.

2. L. Luo, Yiming Qi, Hong Zhong, Shinan Jiang, Hu Zhang, Hao Cai, Yahui Wu, Zhongwei Gu, Qiyong Gong, Kui Luo,*. GSH-sensitive polymeric prodrug: Synthesis and loading with photosensitizers as nanoscale chemo-photodynamic anti-cancer nanomedicine [J]. Acta Pharmaceutica Sinica B, 2022;12(1):424-436.

3. Q. Ren, X. Tang, Y. Lu, Q. Li, Z. Liao, S. Jiang, H. Zhang, Z. Xu, L. Luo*. Design, Preparation and Pharmacodynamics of ICG-Fe(Ⅲ) Based HCPT Nanocrystals Against Cancer [J]. Asian Journal of Pharmaceutical Sciences, 2022, 17(4):596-609.

4. L. Luo, Z. Yin, Y.M. Qi, S. LIU, Y. YI, X.H. TIAN, Y.H. WU, D. ZHONG, Z.W. GU, H. ZHANG, K LUO∗. An intracellular enzyme-responsive polymeric prodrug with synergistic effect of chemotherapy and two-photon photodynamic therapy [J]. Applied Materials Today, 2021, 23: 100996.

5. J.B. Liu, X. Yuan, L.D. Deng, Z. YIN, X.H. TIAN, S. Bhattacharyya, H.R. LIU, Y.H. LUO, L. LUO*. Graphene Oxide activated by 980 nm Laser for Cascading Two-Photon Photodynamic Therapy and Photothermal Therapy Against Breast Cancer[J]. Applied Materials Today, 2020, 20: 100665.

6. L. Luo*, F.S. Xu, H.L. Peng, Y.H. LUO, X.H. TIAN, G. Battaglia, H. ZHANG, Q.Y. GONG, Z.W. GU, K. LUO*. Stimuli-responsive polymeric prodrug-based nanomedicine delivering nifuroxazide and doxorubicin against primary breast cancer and pulmonary metastasis[J]. Journal of Controlled Release, 2020, 318: 124-135.

7. L. Luo*, Q. Zhang, Y.H. Luo, Z.G. HE, X.H. TIAN, G. Battaglia*. Thermosensitive nanocomposite gel for intra-tumoral two-photon photodynamic therapy[J]. Journal of Controlled Release, 2019, 298: 99-109.

8. Y. Qi, M. Jin, Q. Li, Q. Wu, Z. Liao, M. Wei, X. Fan, Q. Yang, X. Tian, B. Giuseppe, L. Luo*.Chitooligosaccharide reconstitutes intestinal mucus layer to improve oral absorption of water-soluble drugs[J]. Journal of Controlled Release, 2023, 360 831–841.

9. Y. Yu, X. Tang, L. Zhou, F. Xu, Y. Zhang, L. Zeng, J. Li, G. Liao*, L. Luo*.Cascade-targeting polymeric particles eliminate intracellular C. neoformans in fungal infection therapy[J]. Journal of Controlled Release, 2024, 373 399–409.

10. Y. Yu*, S. Zhang, Y. Xu, H. Shao,L. Luo*.Oral delivery of ferroptosis inducers for effective treatment of hepatic fibrosis[J]. Nano Research, 2024, 17 7621–7630.